(Q44601151)

English

Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine When Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers (English)

1 reference

Europe PubMed Central

4 December 2017

Pharmacokinetic Interactions between Sirolimus and Microemulsion Cyclosporine When Orally Administered Jointly and 4 Hours Apart in Healthy Volunteers (English)

1 reference

10.1177/0091270003257227

https://api.crossref.org/works/10.1177/0091270003257227

15 March 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1177/0091270003257227

https://api.crossref.org/works/10.1177/0091270003257227

15 March 2024

author name string

Dawn Harper

2

1 reference

Europe PubMed Central

4 December 2017

Jay Getsy

3

1 reference

Europe PubMed Central

4 December 2017

James J. Zimmerman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517200

15 March 2024

William J. Jusko

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517200

15 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14517200

15 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003257227

1 reference

10.1177/0091270003257227

https://api.crossref.org/works/10.1177/0091270003257227

15 March 2024

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003257227

1 reference

10.1177/0091270003257227

https://api.crossref.org/works/10.1177/0091270003257227

15 March 2024

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

4 December 2017

43

1 reference

Europe PubMed Central

4 December 2017

1168-1176

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Clinically significant drug interactions with cyclosporin. An update

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Population pharmacokinetics of sirolimus in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257227

21 January 2018

Identifiers

10.1177/0091270003257227

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44601151&oldid=2102691339"